Source: AAPS Online

Senior Editor:
Jane Orient, MD, Internal Medicine Physician, Executive Director,
Association of American Physicians and Surgeons,
President, Doctors for Disaster Preparedness
Consulting Editor:
Peter A. McCullough, MD, MPH, FACP, FACC, FCCP, FAHA, FNKF, FNLA, FCRSA
Internist, Cardiologist, and Epidemiologist,
President, Cardiorenal Society of America
Editor/Writer:
Elizabeth Lee Vliet, MD, Preventive Medicine
Past Director, Association of American Physicians and Surgeons,
Member of AAPS Editorial Writing Team
Technical Editor:
Jeremy Snavely, Business Manager
Association of American Physicians and Surgeons

Disclaimer: This booklet does not provide individual medical advice or prescribe treatment but is provided as an educational service for patients and their families to know what options are available and widely used for many conditions. Patients should consult the physicians of their choice for individual medical evaluation and recommendations for treatment tailored to individual needs.

INTRODUCTION

A Guide to Home-Based COVID treatment is built on the rapidly accumulating peer-reviewed published medical research, written by practicing physicians with decades of experience treating patients with all kinds of illnesses. We provide a step-by-step guide to medically sound early treatments that have a reasonable probability of success in this emergency pandemic. There are oral medications that are approved for other conditions, but not yet proven to be efficacious specifically for COVID-19 by the U.S. Food and Drug Administration.

In the global pandemic emergency, large scale randomized clinical trials have not been feasible in the face of such critical illness. The National Institutes of Health at this time does not recommend treatment outside of the hospital because there are no current medications specifically approved for outpatient COVID-19 treatment, even though the mortality rate once patients require hospitalization is unacceptably high.

Thus, treatment administered outside of the hospitalized setting should be under the supervision of a physician or licensed medical professional who is knowledgeable in the use of the medications and the monitoring approach for ambulatory, home-based COVID-19 as described in this guide. Patients who worsen in any way should seek
emergency room evaluation immediately.

There are four major pillars to infectious disease pandemic response:
1) Contagion control (stop the spread of the virus)
2) Early ambulatory, home-based treatment
3) Late-stage treatment in hospital
4) Vaccination

This guide will focus on the pillar of early, ambulatory, home-based medical treatment overseen by your physician, using a combination of available medicines, already FDA-approved for other medical conditions, and widely used in clinical medicine every day.

Please download the guide here: CovidPatientTreatmentGuide.pdf







Related: HCQ Protocols from America’s Frontline Doctors

HCQ is effective for COVID-19 when used early: analysis of 132 studies

How hydroxychloroquine works at the cellular level

Hydroxychloroquine linked to reducing ICU admissions among hospitalized COVID-19 patients by 53%

Let’s all be honest about hydroxychloroquine: Evidence is more positive than many in the medical community admit

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

A Conversation With Dr. Brian Tyson – The Chloroquine Wars Part XLI

The data from the vaccine trials must be recalculated under the lens that some of the serious adverse events (SAEs) should be treated as COVID-19 cases.
There may not be any vaccine efficacy in the data at all if some of the post-vaccination deaths are due to vaccine-induced COVID-19. It could even be the case that the mortality efficacy goes negative. My implied lives saved calculations put this easily in the realm of possibility. The only way to know is for authorities to organize and compile the data. And while a risk analysis is certainly due after more than six months of hundreds of millions of doses delivered, there is little indication authorities have bothered with the process. That’s more than a bit unsettling.

Read More »

Dr. Brian Tyson, USA: Hydroxychloroquine – Data, Strategies and Success Treating over 6000 Covid Patients

We continue to delve extensively into the COVID-19 data with esteemed statistician, Mathew Crawford. In this episode, we take a closer look at the use of early treatment and its success. Mathew has been researching the data from Dr. Brian Tyson, who has successfully treated over 6000 patients who contracted COVID throughout the pandemic. It is my great honor to have Dr. Tyson here on this episode to not only discuss the data, but also the strategies that he has been using throughout the pandemic.

Read More »